Diabetes decisions — 2016

The Veteran's diabetes mellitus requires oral agents and a restricted diet, but does not require regulation of activities. The criteria for assignment of a rating in excess of 20 percent have not been met.

The Board is remanding the case to consider whether the Veteran's service in Da Nang Harbor qualifies as in-country service for purposes of herbicide exposure, and to determine if he is entitled to service connection for ischemic heart disease and diabetes mellitus due to such exposure.

The Veteran's service-connected disabilities, including diabetes mellitus type II and bilateral lower extremity diabetic neuropathy, render him unable to obtain and maintain substantially gainful employment. The Board finds that he is entitled to a TDIU.

The Board found that the Veteran's death was not caused by or a result of service-connected conditions, and denied the claim for service connection for the cause of his death.

The Veteran's diabetes mellitus is currently rated at 20 percent, the maximum schedular rating available. The Board finds that his symptoms do not warrant a higher evaluation as he does not require regulation of activities due to medical management of his diabetes.

The Board has determined that the Veteran was exposed to herbicide agents during his service in Thailand and finds that diabetes mellitus is presumed to be related to this exposure.

The Board denied the Veteran's claims for a temporary total evaluation due to treatment of his service-connected left epididymal cyst, as well as his claims for compensable evaluations for his diabetic retinopathy and hypertension. The low back strain claim is remanded.

The Veteran's claim for an increased rating for diabetes mellitus, type II is being remanded due to the need for a new VA examination to assess the current severity of his disability.

The Veteran's diabetes and peripheral neuropathy were granted, with the diabetes receiving a higher rating. The lower extremity diabetic peripheral neuropathy was also granted but at a lower rating.

The Board has decided to remand the case for further development, including scheduling a videoconference hearing at the RO before a Veterans Law Judge.

The Veteran's service-connected disabilities (PTSD, diabetes, and peripheral neuropathy) preclude him from obtaining substantial gainful employment.

The Board has determined that the issues of service connection for an acquired psychiatric disorder, lung condition, vertigo, diabetes mellitus type II, tinnitus, and heart condition are inextricably intertwined with other claims. Therefore, these issues must be remanded to allow for further development.

The Board has determined that the Veteran's service connection for type 2 diabetes mellitus is granted due to exposure to herbicides during his service at Ubon Airfield, Thailand.

[object Object]

The Board found no evidence to support the Veteran's claim of service connection for diabetes mellitus type II based on herbicide exposure, and denied the claim.

The Veteran's claims for service connection are being remanded due to the need to obtain deck logs for his ship, U.S.S. Tripoli, to determine if he was exposed to herbicides during his service.

The Veteran's claims for diabetes mellitus, peripheral neuropathy, heart disorder, and arthritis were denied as they are not related to service or a service-connected disability. The exposure basis was not applicable due to lack of in-service Vietnam service.

The Board has denied the Veteran's claims for service connection for prostate cancer and diabetes mellitus, finding that there is no evidence of a nexus between these conditions and his period of active duty.

The Board denied the Veteran's claims for service connection for hypertension, diabetes mellitus, Type II, a lumbar spine disability, an acquired psychiatric disability (claimed as depression), sleep apnea, and gastrointestinal reflux disorder (GERD).

The Board has remanded the case for a video conference hearing, as the Veteran requested one but no such hearing was scheduled. The claims related to diabetes mellitus and peripheral neuropathy are being reopened due to new evidence.